PEAK6 Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,000
Closed -$237K 4946
2020
Q1
$237K Buy
+6,000
New +$351K ﹤0.01% 2698
2019
Q4
Sell
-6,500
Closed -$346K 4250
2019
Q3
$346K Buy
+6,500
New +$334K ﹤0.01% 2551
2018
Q4
Sell
-400
Closed -$21K 4865
2018
Q3
$21K Buy
+400
New +$19.6K ﹤0.01% 3911

Other funds holding SYNH

PEAK6 Investments's SYNH Position: Q2 2021 in Review

PEAK6 Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 24,846 shares — an estimated $1.89M sold.

PEAK6 Investments first reported a position in SYNH in Q3 2018 and held it in 3 quarters. The position peaked at $1.89M in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • PEAK6 Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • PEAK6 Investments sold 24,846 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $1.89M.
  • PEAK6 Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2018 and held it in 3 quarters.
  • PEAK6 Investments's Syneos Health, Inc. Class A Common Stock position peaked at $1.89M in Q1 2021.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.